Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1989 May;27(5):1011–1014. doi: 10.1128/jcm.27.5.1011-1014.1989

Serological classification of Xanthomonas maltophilia (Pseudomonas maltophilia) based on heat-stable O antigens.

B Schable 1, D L Rhoden 1, R Hugh 1, R E Weaver 1, N Khardori 1, P B Smith 1, G P Bodey 1, R L Anderson 1
PMCID: PMC267473  PMID: 2473089

Abstract

Twenty-six serotypes of Xanthomonas maltophilia were defined by using 15 antisera described by Hugh and Ryschenkow (R. Hugh and E. Ryschenkow, J. Gen. Microbiol. 26:123-132, 1961) and 11 new antisera. The antisera were prepared by immunizing rabbits with bacterial strains heated at 100 degrees C for 2 h. Twelve antisera required adsorptions with cross-reacting heterologous immunizing strains. We tested 275 clinical and environmental strains of X. maltophilia with 26 antisera by the slide agglutination technique. A total of 259 (94.2%) strains were typeable, with 137 (49.8%) strains agglutinating in three antisera.

Full text

PDF
1011

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Felegie T. P., Yu V. L., Rumans L. W., Yee R. B. Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother. 1979 Dec;16(6):833–837. doi: 10.1128/aac.16.6.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gardner P., Griffin W. B., Swartz M. N., Kunz L. J. Nonfermentative gram-negative bacilli of nosocomial interest. Am J Med. 1970 Jun;48(6):735–749. doi: 10.1016/s0002-9343(70)80009-2. [DOI] [PubMed] [Google Scholar]
  3. Gilardi G. L. Infrequently encountered Pseudomonas species causing infection in humans. Ann Intern Med. 1972 Aug;77(2):211–215. doi: 10.7326/0003-4819-77-2-211. [DOI] [PubMed] [Google Scholar]
  4. Gilardi G. L. Pseudomonas maltophilia infections in man. Am J Clin Pathol. 1969 Jan;51(1):58–61. doi: 10.1093/ajcp/51.1.58. [DOI] [PubMed] [Google Scholar]
  5. Grimont F., Grimont P. A. Ribosomal ribonucleic acid gene restriction patterns as potential taxonomic tools. Ann Inst Pasteur Microbiol. 1986 Sep-Oct;137B(2):165–175. doi: 10.1016/s0769-2609(86)80105-3. [DOI] [PubMed] [Google Scholar]
  6. HUGH R., RYSCHENKOW E. Pseudomonas maltophilia, an alcaligenes-like species. J Gen Microbiol. 1961 Sep;26:123–132. doi: 10.1099/00221287-26-1-123. [DOI] [PubMed] [Google Scholar]
  7. Holmes B., Lapage S. P., Easterling B. G. Distribution in clinical material and identification of Pseudomonas maltophilia. J Clin Pathol. 1979 Jan;32(1):66–72. doi: 10.1136/jcp.32.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mikkelsen O. S. Serotyping of Pseudomonas aeruginosa. 2. Results of an O group classification. Acta Pathol Microbiol Scand B Microbiol Immunol. 1970;78(2):163–175. [PubMed] [Google Scholar]
  9. Moody M. R., Young V. M., Kenton D. M. In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients. Antimicrob Agents Chemother. 1972 Nov;2(5):344–349. doi: 10.1128/aac.2.5.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Morrison A. J., Jr, Hoffmann K. K., Wenzel R. P. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol. 1986 Jul;24(1):52–55. doi: 10.1128/jcm.24.1.52-55.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Muder R. R., Yu V. L., Dummer J. S., Vinson C., Lumish R. M. Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. Arch Intern Med. 1987 Sep;147(9):1672–1674. [PubMed] [Google Scholar]
  12. Nagai T. Association of Pseudomonas maltophilia with malignant lesions. J Clin Microbiol. 1984 Nov;20(5):1003–1005. doi: 10.1128/jcm.20.5.1003-1005.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Narasimhan S. L., Gopaul D. L., Hatch L. A. Pseudomonas maltophilia bacteremia associated with a prolapsed mitral valve. Am J Clin Pathol. 1977 Aug;68(2):304–306. doi: 10.1093/ajcp/68.2.304. [DOI] [PubMed] [Google Scholar]
  14. Nord C. E., Wadström T., Wretlind B. Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrob Agents Chemother. 1974 Oct;6(4):521–523. doi: 10.1128/aac.6.4.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schoch P. E., Cunha B. A. Pseudomonas maltophilia. Infect Control. 1987 Apr;8(4):169–172. doi: 10.1017/s019594170006584x. [DOI] [PubMed] [Google Scholar]
  16. Selander R. K., Caugant D. A., Ochman H., Musser J. M., Gilmour M. N., Whittam T. S. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol. 1986 May;51(5):873–884. doi: 10.1128/aem.51.5.873-884.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wishart M. M., Riley T. V. Infection with Pseudomonas maltophilia hospital outbreak due to contaminated disinfectant. Med J Aust. 1976 Nov 6;2(19):710–712. doi: 10.5694/j.1326-5377.1976.tb128238.x. [DOI] [PubMed] [Google Scholar]
  18. Yu V. L., Felegie T. P., Yee R. B., Pasculle A. W., Taylor F. H. Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia. J Infect Dis. 1980 Oct;142(4):602–607. doi: 10.1093/infdis/142.4.602. [DOI] [PubMed] [Google Scholar]
  19. Zuravleff J. J., Yu V. L. Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. Rev Infect Dis. 1982 Nov-Dec;4(6):1236–1246. doi: 10.1093/clinids/4.6.1236. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES